These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36561520)

  • 1. Erratum: Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
    Frontiers Production Office
    Front Oncol; 2022; 12():1085757. PubMed ID: 36561520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma.
    Dong T; Zhang B; Zhang R; Wang C; Liu X; Wang F; Hao N; Tan K; Chang YZ
    Front Oncol; 2022; 12():963096. PubMed ID: 36237302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin Upregulation in Lung Cancer: A Potential Therapeutic Target Associated With Immune Infiltration.
    Fan Y; Liu B; Chen F; Song Z; Han B; Meng Y; Hou J; Cao P; Chang Y; Tan K
    Front Immunol; 2021; 12():612144. PubMed ID: 33868231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma.
    Zhou Z; Wu J; Yang Y; Gao P; Wang L; Wu Z
    Am J Cancer Res; 2022; 12(9):4120-4139. PubMed ID: 36225649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():979968. PubMed ID: 36072794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.
    Yan T; Tian D; Chen J; Tan Y; Cheng Y; Ye L; Deng G; Liu B; Yuan F; Zhang S; Cai L; Chen Q
    Front Oncol; 2021; 11():769033. PubMed ID: 35047393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.
    Cheng F; Zhang P; Xiao Q; Li Y; Dong M; Wang H; Kuang D; He Y; Duan Q; Mao F; Wang B; Guo D
    Front Oncol; 2020; 10():591112. PubMed ID: 33102241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer.
    Frontiers Production Office
    Front Oncol; 2021; 11():715746. PubMed ID: 34222032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors.
    Frontiers Production Office
    Front Oncol; 2023; 13():1136978. PubMed ID: 36741024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDELR1 Is an Independent Prognostic Predictor and Correlates With Immunity in Glioma.
    Yuan Y; Yang B; Qi Z; Han Z; Cai J; Song J
    Front Oncol; 2022; 12():783721. PubMed ID: 35814367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: The Emerging Role of Extracellular Vesicle-Associated RNAs in the Multiple Myeloma Microenvironment.
    Frontiers Production Office
    Front Oncol; 2021; 11():740028. PubMed ID: 34386432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Medicine, Volume 95, Issue 24: Erratum.
    Medicine (Baltimore); 2016 Aug; 95(31):e5074. PubMed ID: 31265618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Medicine, Volume 95, Issue 23: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(28):e0916. PubMed ID: 31265603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Body Composition Parameters May Be Prognostic Factors in Upper Urinary Tract Urothelial Carcinoma Treated by Radical Nephroureterectomy.
    Frontiers Production Office
    Front Oncol; 2021; 11():740572. PubMed ID: 34368007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.
    Chen Q; Tan Y; Zhang C; Zhang Z; Pan S; An W; Xu H
    Front Oncol; 2021; 11():683333. PubMed ID: 33937088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Tumor response assessment on imaging following immunotherapy.
    Frontiers Production Office
    Front Oncol; 2023; 13():1175321. PubMed ID: 36959791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Risk factors of brain metastasis and prognosis in HER2-positive breast cancer: A single-institution retrospective analysis from China.
    Front Oncol; 2022; 12():1027199. PubMed ID: 36203465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma.
    Zhang Y; Yang X; Zhu XL; Wang ZZ; Bai H; Zhang JJ; Hao CY; Duan HB
    Front Oncol; 2021; 11():643159. PubMed ID: 33937046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.